IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GRISANTI, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.149
EU - Europa 2.344
AS - Asia 1.607
AF - Africa 20
SA - Sud America 11
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.139
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.119
SG - Singapore 555
CN - Cina 549
IT - Italia 446
UA - Ucraina 417
PL - Polonia 365
DE - Germania 300
FI - Finlandia 217
HK - Hong Kong 216
RU - Federazione Russa 148
TR - Turchia 133
IE - Irlanda 130
GB - Regno Unito 90
FR - Francia 73
CZ - Repubblica Ceca 52
ID - Indonesia 48
SE - Svezia 37
IN - India 34
VN - Vietnam 32
CA - Canada 27
BE - Belgio 26
JP - Giappone 15
NL - Olanda 10
CH - Svizzera 7
GR - Grecia 7
AZ - Azerbaigian 6
IR - Iran 5
LY - Libia 5
PT - Portogallo 5
AU - Australia 4
MU - Mauritius 4
TW - Taiwan 4
BR - Brasile 3
EG - Egitto 3
EU - Europa 3
MA - Marocco 3
AL - Albania 2
AR - Argentina 2
CL - Cile 2
CR - Costa Rica 2
NO - Norvegia 2
PH - Filippine 2
TH - Thailandia 2
ZA - Sudafrica 2
ZW - Zimbabwe 2
AT - Austria 1
BO - Bolivia 1
CM - Camerun 1
CO - Colombia 1
CY - Cipro 1
EE - Estonia 1
ES - Italia 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
SI - Slovenia 1
Totale 9.139
Salva come PNG Salva come JPEG
Città #
Fairfield 746
Woodbridge 532
Singapore 485
Ashburn 439
Houston 384
Warsaw 365
Jacksonville 308
Cambridge 305
Seattle 304
Chandler 301
Wilmington 246
Hong Kong 214
Princeton 178
Helsinki 173
Ann Arbor 166
New York 149
Istanbul 130
Dublin 98
Beijing 90
Nanjing 86
Moscow 85
Brescia 71
Boardman 70
Shanghai 61
Dearborn 50
Jakarta 48
Munich 43
Brno 42
Los Angeles 37
Milan 35
San Diego 35
Des Moines 34
Nanchang 34
Dong Ket 32
Changsha 29
Dalmine 29
Romola 29
Washington 27
Brussels 26
West Jordan 26
Shenyang 25
Menlo Park 22
Lancaster 21
Jinan 19
Tianjin 17
Hebei 16
London 16
Naples 16
Toronto 16
San Francisco 13
Hangzhou 12
Vignate 12
Guangzhou 10
Jiaxing 10
Kunming 10
Pune 10
Turin 10
Verona 10
Zhengzhou 10
Gumyojicho 9
Haikou 9
Ningbo 9
Olomouc 9
Taizhou 9
Chicago 8
Falls Church 7
Lanzhou 7
Lappeenranta 7
Redwood City 7
Rome 7
Athens 6
Cazzago San Martino 6
Falkenstein 6
Fukuoka 6
Leawood 6
Livorno 6
Ottawa 5
Perugia 5
Santa Clara 5
Baku 4
Brusaporto 4
Espoo 4
Frankfurt am Main 4
Gunzenhausen 4
New Bedfont 4
North York 4
Norwalk 4
Phoenix 4
San Mateo 4
Ventimiglia 4
Ardabil 3
Augusta 3
Benghazi 3
Borås 3
Castelmola 3
Chiswick 3
Dietikon 3
Gardone Val Trompia 3
Kocaeli 3
Lisbon 3
Totale 7.030
Salva come PNG Salva come JPEG
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 192
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 178
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 177
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 169
Immunotherapy failure in adrenocortical cancer: where next? 165
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 157
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 152
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 151
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 149
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 148
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 148
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 146
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 145
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 144
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 133
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 132
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 126
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 123
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 119
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 118
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 118
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 116
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 116
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 114
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 112
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 111
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 110
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 110
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 110
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 110
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 109
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 109
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 109
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 109
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update 105
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 103
Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer. 100
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial 99
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 99
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 98
Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy 97
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 96
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 95
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 94
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 93
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 92
An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial 91
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 89
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 88
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. 87
Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma 87
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 87
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 85
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 83
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 81
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 81
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 74
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 68
Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma 65
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 63
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 61
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 61
Dynamic Susceptibility Contrast MR Imaging inGlioblastomas: Correlation of Whole-TumorHistogram Analysis of the Normalized CerebralBlood Volume and Vascular Permeability withHistopathologic and Molecular Markers of TumorAggressiveness 59
Targeted therapy with trastuzumab in dysplasia and adenocarcinoma arising in Barrett’s esophagus: a traslational approach 58
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 58
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 56
Comparison of the prognostic classification with recursive partitioning analysis (RPA) and general prognostic assessment (GPA) in a retrospective analysis of 430 patients with brain metastases 54
TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma 54
Targeted therapy with trastuzumab in Barrett’s dysplasia and adenocarcinoma: a translational approach 53
Topo IIα and HER-2/neu Overexpression/Amplification in Barrett's Esophagus, Dysplasia and Adenocarcinoma 53
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 53
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 52
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 51
null 50
HER-2 overexpression/amplification in esophageal dysplasia predicts early transition to adenocarcinoma: a clinico-pathologic study 49
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 49
Retrospective analysis of 107 patients whit localized extranodal limphoma of the head and neck treated with radiotherapy alone or combined modality treatment: final analysis of response rate, survival and pattern of relapse 48
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 48
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 46
HER-2/neu in Barrett’s esophagus: immunohistochemistry and fluorescence in situ hybridization (FISH) to identify a new subgroup of patients. 45
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 44
Could a comprehensive urinary endogenous steroidal profile improve the accuracy of prostate-specific antigen screening? 44
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 44
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 41
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 41
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 41
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 39
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 38
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 38
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 36
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 36
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 36
Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases 35
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 34
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 33
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 32
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 30
Is BMI a reliable prognostic parameter in metastatic prostate cancer patients? 30
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 29
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation 29
Totale 8.623
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.236 0 0 0 0 0 225 200 217 177 206 85 126
2020/20211.656 52 175 110 216 103 173 52 171 150 214 123 117
2021/2022848 67 82 30 96 22 53 36 56 43 108 64 191
2022/2023823 106 53 42 63 70 191 5 74 119 22 44 34
2023/20241.474 71 41 133 93 104 269 46 79 226 69 49 294
2024/20251.389 50 47 62 557 406 267 0 0 0 0 0 0
Totale 9.426